RetinalGenix Technologies Inc. (RTGN)

Market Cap	59.54M
Revenue (ttm)	n/a
Net Income	-2.67M
EPS	-0.14
Shares Out	18.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	1,703
Open	3.200
Previous Close	3.550
Day's Range	3.200 - 3.200
52-Week Range	0.250 - 6.360
Beta	-3.92
RSI	47.87
Earnings Date	Mar 31, 2026

About RetinalGenix Technologies

RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. Its products include the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remote location patient-activated monitoring and imaging device offering real-time communication and alerting system for physicians. It also develops RTG-20...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: RTGN